Search Constraints
« Previous |
101 - 120 of 273
|
Next »
Search Results
Select an image to start the slideshow
Structural Consequences of and Mechanistic Insights into the DNA- and Field-Directed Crystallization of Iron Oxide Nanoparticles.
1 of 20
Protein Stabilization with Metal–Organic Frameworks for Drug Delivery and Catalysis
2 of 20
Gold Nanostars: Importance of Nanoparticle Shape at The Single-Particle Level
3 of 20
Photophysics of Colloidal Two-Dimensional Semiconductor Nanoparticles
4 of 20
Materials and Models for Coexisting Metallic Conductivity and Broken Inversion Symmetry
5 of 20
Design and Synthesis of Imine-Linked Two-Dimensional Covalent Organic Frameworks
6 of 20
Synthesis and Characterization of Low-Dimensional Materials for Dynamic Reconfigurability in Mixed-Dimensional Heterostructures
7 of 20
Traceless Immobilization of Analytes for High-Throughput Experimenting with SAMDI Mass Spectrometry
8 of 20
Making Magnesium Mobile: Cathodes for Multivalent Battery Systems
9 of 20
Investigating Nanoparticle-Cell Interactions at Single-Nanoconstruct Level
10 of 20
Programming Assembly Pathways of Proteins Using DNA
11 of 20
Non-Equilibrium Structural and Electronic Dynamics in Perovskite Semiconductors
12 of 20
Assembly and Optical Properties of Colloidal Metacrystals Engineered with DNA
13 of 20
Inhibition of amyloid beta oligomer formation, binding, and downstream tau phosphorylation: three potential therapeutic approaches for Alzheimer’s disease
14 of 20
Design and Characterization of Therapeutic Gold Nanostars
15 of 20
Data-driven Functional Materials Design and Discovery
16 of 20
Development of Theranostic and Bioresponsive Small Molecule Magnetic Resonance Imaging Contrast Agents
17 of 20
Inhibition of amyloid beta oligomer formation, binding, and downstream tau phosphorylation: three potential therapeutic approaches for Alzheimer’s disease
18 of 20
Light-Driven Carbene Catalysis for the Synthesis of Carbonyl Compounds
19 of 20
Lanthanide-Organic Catalysis: Metal-Based Chemodivergence and the Importance of Chemically Non-Innocent Ligand Participation
20 of 20